Skip to main content
Premium Trial:

Request an Annual Quote

Datavant: Mark Karch

Datavant has hired Mark Karch as chief commercial officer. He comes the startup health data integrator and analytics firm from IQvia, where he led software-as-a-service technology sales following that company's acquistion of Appature, where Karch had been executive VP of commercialization. Karch also was EVP of the former pharmaceutical business at Allscripts Healthcare Solutions, the health IT vendor with roots in drug repackaging.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.